img

Global Bulk Drug Intermediates Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Bulk Drug Intermediates Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Bulk Drug Intermediates Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Bulk Drug Intermediates industry at home and abroad, estimate the overall market scale of the Bulk Drug Intermediates industry and the market share of major countries, Bulk Drug Intermediates industry, and study and judge the downstream market demand of Bulk Drug Intermediates through systematic research, Analyze the competition pattern of Bulk Drug Intermediates, so as to help solve the pain points of various stakeholders in Bulk Drug Intermediates industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Bulk Drug Intermediates Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Bulk Drug Intermediates Market?
Lonza
Catalent
Patheon
Jubilant
Granules
Ganesh
Chemcon
BASF
Porton
Lianhetech
ABA Chem
Tianma
Jiujiujiu
Alpha
Jiuzhou
Yongtai
Major Type of Bulk Drug Intermediates Covered in XYZResearch report
GMP
Non-GMP
Application Segments Covered in XYZResearch Market
Antibiotics
Antipyretic Analgesics
Vitamins
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Bulk Drug Intermediates Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Bulk Drug Intermediates Market by Value
2.2.1 Global Bulk Drug Intermediates Revenue by Type
2.2.2 Global Bulk Drug Intermediates Market by Value (%)
2.3 Global Bulk Drug Intermediates Market by Production
2.3.1 Global Bulk Drug Intermediates Production by Type
2.3.2 Global Bulk Drug Intermediates Market by Production (%)

3. The Major Driver of Bulk Drug Intermediates Industry
3.1 Historical & Forecast Global Bulk Drug Intermediates Demand
3.2 Largest Application for Bulk Drug Intermediates (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Bulk Drug Intermediates Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Bulk Drug Intermediates Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Bulk Drug Intermediates Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Bulk Drug Intermediates Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Bulk Drug Intermediates Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Bulk Drug Intermediates Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Bulk Drug Intermediates Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Bulk Drug Intermediates Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Bulk Drug Intermediates Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Bulk Drug Intermediates Average Price Trend
12.1 Market Price for Each Type of Bulk Drug Intermediates in US (2018-2022)
12.2 Market Price for Each Type of Bulk Drug Intermediates in Europe (2018-2022)
12.3 Market Price for Each Type of Bulk Drug Intermediates in China (2018-2022)
12.4 Market Price for Each Type of Bulk Drug Intermediates in Japan (2018-2022)
12.5 Market Price for Each Type of Bulk Drug Intermediates in India (2018-2022)
12.6 Market Price for Each Type of Bulk Drug Intermediates in Korea (2018-2022)
12.7 Market Price for Each Type of Bulk Drug Intermediates in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Bulk Drug Intermediates Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Bulk Drug Intermediates

14. Bulk Drug Intermediates Competitive Landscape
14.1 Lonza
14.1.1 Lonza Company Profiles
14.1.2 Lonza Product Introduction
14.1.3 Lonza Bulk Drug Intermediates Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Catalent
14.2.1 Catalent Company Profiles
14.2.2 Catalent Product Introduction
14.2.3 Catalent Bulk Drug Intermediates Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Patheon
14.3.1 Patheon Company Profiles
14.3.2 Patheon Product Introduction
14.3.3 Patheon Bulk Drug Intermediates Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Jubilant
14.4.1 Jubilant Company Profiles
14.4.2 Jubilant Product Introduction
14.4.3 Jubilant Bulk Drug Intermediates Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Granules
14.5.1 Granules Company Profiles
14.5.2 Granules Product Introduction
14.5.3 Granules Bulk Drug Intermediates Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Ganesh
14.6.1 Ganesh Company Profiles
14.6.2 Ganesh Product Introduction
14.6.3 Ganesh Bulk Drug Intermediates Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Chemcon
14.7.1 Chemcon Company Profiles
14.7.2 Chemcon Product Introduction
14.7.3 Chemcon Bulk Drug Intermediates Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 BASF
14.8.1 BASF Company Profiles
14.8.2 BASF Product Introduction
14.8.3 BASF Bulk Drug Intermediates Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Porton
14.9.1 Porton Company Profiles
14.9.2 Porton Product Introduction
14.9.3 Porton Bulk Drug Intermediates Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Lianhetech
14.10.1 Lianhetech Company Profiles
14.10.2 Lianhetech Product Introduction
14.10.3 Lianhetech Bulk Drug Intermediates Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 ABA Chem
14.12 Tianma
14.13 Jiujiujiu
14.14 Alpha
14.15 Jiuzhou
14.16 Yongtai
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Bulk Drug Intermediates Industry (Volume)
Figure 2. Bulk Drug Intermediates Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Bulk Drug Intermediates Revenue in 2022
Figure 5. US Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Bulk Drug Intermediates Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Bulk Drug Intermediates Revenue, by Type (Million USD) (2018-2028)
Table 4. Bulk Drug Intermediates Production, by Type (K Unit) (2018-2028)
Table 5. Bulk Drug Intermediates Demand (K Unit) by Application (2018-2028)
Table 6. Bulk Drug Intermediates Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Bulk Drug Intermediates Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Bulk Drug Intermediates Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Bulk Drug Intermediates in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Lonza Profiles
Table 61. Lonza Bulk Drug Intermediates Product Introduction
Table 62. Lonza Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Lonza Strategic initiatives
Table 64. Catalent Profiles
Table 65. Catalent Bulk Drug Intermediates Product Introduction
Table 66. Catalent Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Catalent Strategic initiatives
Table 68. Patheon Profiles
Table 69. Patheon Bulk Drug Intermediates Product Introduction
Table 70. Patheon Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Patheon Strategic initiatives
Table 72. Jubilant Profiles
Table 73. Jubilant Bulk Drug Intermediates Product Introduction
Table 74. Jubilant Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Jubilant Strategic initiatives
Table 76. Granules Profiles
Table 77. Granules Bulk Drug Intermediates Product Introduction
Table 78. Granules Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Granules Strategic initiatives
Table 80. Ganesh Profiles
Table 81. Ganesh Bulk Drug Intermediates Product Introduction
Table 82. Ganesh Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Ganesh Strategic initiatives
Table 84. Chemcon Profiles
Table 85. Chemcon Bulk Drug Intermediates Product Introduction
Table 86. Chemcon Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Chemcon Strategic initiatives
Table 88. BASF Profiles
Table 89. BASF Bulk Drug Intermediates Product Introduction
Table 90. BASF Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. BASF Strategic initiatives
Table 92. Porton Profiles
Table 93. Porton Bulk Drug Intermediates Product Introduction
Table 94. Porton Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Porton Strategic initiatives
Table 97. Lianhetech Profiles
Table 98. Lianhetech Bulk Drug Intermediates Product Introduction
Table 99. Lianhetech Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Lianhetech Strategic initiatives
Table 101. ABA Chem Profiles
Table 102. ABA Chem Bulk Drug Intermediates Product Introduction
Table 103. ABA Chem Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. ABA Chem Strategic initiatives
Table 105. Tianma Profiles
Table 106. Tianma Bulk Drug Intermediates Product Introduction
Table 107. Tianma Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Tianma Strategic initiatives
Table 109. Jiujiujiu Profiles
Table 110. Jiujiujiu Bulk Drug Intermediates Product Introduction
Table 111. Jiujiujiu Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Jiujiujiu Strategic initiatives
Table 113. Alpha Profiles
Table 114. Alpha Bulk Drug Intermediates Product Introduction
Table 115. Alpha Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Alpha Strategic initiatives
Table 117. Jiuzhou Profiles
Table 118. Jiuzhou Bulk Drug Intermediates Product Introduction
Table 119. Jiuzhou Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Jiuzhou Strategic initiatives
Table 121. Yongtai Profiles
Table 122. Yongtai Bulk Drug Intermediates Product Introduction
Table 123. Yongtai Bulk Drug Intermediates Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Yongtai Strategic initiatives